AbbVie Ordered To Pay $140.1M Awarded In Retrial Of AndroGel MDL Bellwether Case
CHICAGO — An Illinois federal jury on Oct. 5 awarded an AndroGel heart attack plaintiff $140.1 million in a testosterone replacement therapy multidistrict litigation retrial (Jeffrey Konrad, et al. v. AbbVie,...To view the full article, register now.
Already a subscriber? Click here to view full article